J, X., C, N., L, Q., & P, W. (2026). Hyperprogressive disease in carcinoma induced by immune checkpoint inhibitor therapy: A systematic review. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. https://doi.org/10.1007/s12094-026-04330-8
Chicago Style (17th ed.) CitationJ, Xu, Ni C, Qin L, and Wang P. "Hyperprogressive Disease in Carcinoma Induced by Immune Checkpoint Inhibitor Therapy: A Systematic Review." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026. https://doi.org/10.1007/s12094-026-04330-8.
MLA (9th ed.) CitationJ, Xu, et al. "Hyperprogressive Disease in Carcinoma Induced by Immune Checkpoint Inhibitor Therapy: A Systematic Review." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026, https://doi.org/10.1007/s12094-026-04330-8.
